<DOC>
	<DOCNO>NCT00452517</DOCNO>
	<brief_summary>During 6-month period 119 patient acute coronary syndrome , randomize either stent graft group ( n=40 ) , sirolimus elute stent group ( n=39 ) , bare metal stent group ( n=40 ) . Demographic , angiographic procedural characteristic similar three group . The incidence 6-month major adverse coronary event analyse .</brief_summary>
	<brief_title>Comparison Stent Graft , Sirolimus Stent , Bare Metal Stent Implanted Patients With Acute Coronary Syndrome</brief_title>
	<detailed_description>Background : Percutaneous coronary intervention stent implantation standard therapy patient acute coronary syndrome . The in-stent restenosis still problem . Recently , drug elute stent reduce incidence unfavorable event . The primary role polytetrafluoroethylene stent graft ( PTFE ) management coronary perforation , closure coronary aneurysm , degenerate saphenous vein graft . We compare stent native coronary vessel patient acute coronary syndrome sirolimus bare metal stent , possible reduction in-stent restenosis . Methods result : During 6-month period 119 patient acute coronary syndrome , randomize either stent graft group ( n=40 ) , sirolimus elute stent group ( n=39 ) , bare metal stent group ( n=40 ) . Demographic , angiographic procedural characteristic similar three group . The incidence 6-month major adverse coronary event similar three group . The target lesion revascularisation high bare metal stent group ( P=0.044 ) . The primary end-point , restenosis rate six-month follow-up high bare metal stent group , compare stent graft sirolimus elute stent group . The percent diameter stenosis follow-up significantly high bare metal stent group ( P=0.005 ) . The late loss significantly low sirolimus elute stent group ( 0.23 mm ) , compare bare metal stent group ( P= 0.034 ) . There trend low late loss stent graft group , compare bare metal stent group . Conclusion : Three group stent implanted patient acute coronary syndrome ( stent-graft , sirolimus bare metal ) , differ regard incidence major adverse cardiac event . Sirolimus-eluting stent low incidence in-stent restenosis comparison bare metal stent group . Stent graft implant native coronary artery appear safe efficient patient acute coronary syndrome , significant reduction in-stent restenosis achieve .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>stent implantation acute coronary syndrome previous percutaneous coronary intervention coronary artery bypass graft surgery multivessel , diffuse disease , tortuous vessel artery less 3 mm diameter distal stenosis location leave main bifurcation lesion</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>bare metal stent</keyword>
	<keyword>sirolimus-eluting stent</keyword>
	<keyword>coronary polytetrafluoroethylene stent graft</keyword>
	<keyword>acute coronary syndrome</keyword>
	<keyword>quantitative coronary angiography analysis</keyword>
	<keyword>major adverse cardiac event</keyword>
	<keyword>in-stent restenosis</keyword>
	<keyword>target lesion revascularisation</keyword>
</DOC>